MM Pharminvest
0818.473.231 · rovalta.com · 26/09/2026
NORMAL SITUATION
MM Pharminvest
Company — Normal situation.
Financial year 2023 · Closed on 31/12/2023
Net result113,1 k €+1,7 %over 1 year
Gross margin131,2 k €+10,8 %over 1 year
Equity74,3 k €+1,6 %over 1 year
Workforce0,0 ETP
Overview
Identity
Source · BCE/KBOMM Pharminvest is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0818.473.231
- Legal form
- Private company with limited liability
- Contributed capital
- 50 000,00 €
- Latest accounts
- 31/12/2023
- Average workforce
- 0,0 ETP
Signals
ProfitableGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 14 filingsTrend over 12 financial years
| 2023 | 2022 | 2021 | 2018 | 2017 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 131,2 k € | +10.8% | 118,4 k € | +5.7% | 112,1 k € | +3.0% | 108,9 k € | +2.1% | 106,6 k € |
| EBITDA | 130,6 k € | +10.8% | 117,9 k € | +5.7% | 111,5 k € | +3.0% | 108,3 k € | +2.1% | 106 k € |
| Operating result | 130,6 k € | +10.8% | 117,9 k € | +5.7% | 111,5 k € | +302% | 27,7 k € | +8.9% | 25,4 k € |
| Net result | 113,1 k € | +1.7% | 111,2 k € | +18.7% | 93,7 k € | +2276% | 3,9 k € | +125% | 1,7 k € |
| Balance sheet | |||||||||
| Equity | 74,3 k € | +1.6% | 73,1 k € | +1.7% | 71,9 k € | +519% | -17,2 k € | +18.7% | -21,1 k € |
| Total assets | 437,6 k € | -33.8% | 660,6 k € | +19.8% | 551,2 k € | +5.6% | 521,9 k € | +0.7% | 518 k € |
| Cash | 202,6 k € | -53.8% | 438,8 k € | +41.1% | 310,9 k € | +86.7% | 166,6 k € | +6.7% | 156,1 k € |
| Debts | 363,3 k € | -38.2% | 587,5 k € | +22.6% | 479,3 k € | -11.1% | 539 k € | -0.0% | 539,2 k € |
| Other | |||||||||
| Workforce | 0,0 ETP | 0,0 ETP | – | – | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20231 active · 4 ended
Active mandates
Active
Ended mandates
Financials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 |
| Closing of the financial year | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 11/07/2024 | 21/08/2023 | 15/07/2022 | 16/07/2021 | 10/07/2020 | 26/08/2019 |
| General meeting | 26/06/2024 | 28/06/2023 | 29/06/2022 | 30/06/2021 | 24/06/2020 | 26/06/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2023 | 26/06/2024 | 11/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 28/06/2023 | 21/08/2023 | Dutch | |
| Abridged model | 31/12/2021 | 29/06/2022 | 15/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 30/06/2021 | 16/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 24/06/2020 | 10/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 26/06/2019 | 26/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 27/06/2018 | 24/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 28/06/2017 | 19/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 29/06/2016 | 19/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 29/07/2015 | 24/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 09/07/2014 | 22/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 26/06/2013 | 16/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 22/06/2012 | 16/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 29/06/2011 | 19/07/2011 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20231 active · 4 ended
Active mandates
Active
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution12/09/2024RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...) - RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
- Restructuring25/06/2024RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Mandates09/08/2021ONTSLAGEN - BENOEMINGEN
- Other22/09/2009RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 2023113,1 k €↑
- 2022Annual accounts 2022111,2 k €↑
- 2021Annual accounts 202193,7 k €↑
- 2018Annual accounts 20183,9 k €↑
- 2017Annual accounts 20171,7 k €↑
- 2016Annual accounts 2016-156,7 €↑
- 2015Annual accounts 2015-2,8 k €↑
- 2014Annual accounts 2014-4,3 k €↑
- 2013Annual accounts 2013-7,4 k €↑
- 2012Annual accounts 2012-14,2 k €↑
- 2011Annual accounts 2011-18,8 k €↑
- 2010Annual accounts 2010-25,1 k €